A Study of the Safety of INCB054707 in Participants With Hidradenitis Suppurativa

NCT03569371 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Hidradenitis Suppurativa

Interventions

DRUG: INCB054707

Sponsor

Incyte Corporation